Abstract
Introduction: Pre-operative positive lymph node biopsy has been considered synchronous with high axillary disease burden and subsequent axillary clearance. Our study aimed to evaluate if a subgroup exists with minimal disease of <3 lymph nodes in patients with clinically node negative early breast cancer and biopsy proven axilla. Such patients could avoid axillary clearance and have treatment extrapolated on Z-11 and AMAROS trials.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
